TrialMolecular medicine (Cambridge, Mass.)2011

Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients.

Hannelore Ehrenreich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.